Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bullets
2013 ◽
Vol 14
(5)
◽
pp. 597-608
◽
2018 ◽
Vol 10
(1)
◽
pp. 106-108
◽
2018 ◽
Vol 33
(4)
◽
pp. 549-550
2012 ◽
2018 ◽
Vol 13
(10)
◽
pp. S582
◽